S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

KZR Kezar Life Sciences Inc

0.664

-0.0185 (-2.71%)

18 Jun 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Kezar Life Sciences Charts.

Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Kezar Life Sciences Charts.

Kezar Life Sciences Inc News

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Saturday 8 June 2024 (1 week ago) • Business Wire

Form 8-K - Current report
Wednesday 5 June 2024 (2 weeks ago) • Edgar (US Regulatory)

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
Thursday 30 May 2024 (3 weeks ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 May 2024 (1 month ago) • Edgar (US Regulatory)

Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
Friday 10 May 2024 (1 month ago) • Business Wire

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Tuesday 7 May 2024 (1 month ago) • Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Tuesday 9 April 2024 (2 months ago) • Business Wire

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Friday 15 March 2024 (3 months ago) • Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Saturday 9 March 2024 (3 months ago) • Business Wire

Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
Thursday 29 February 2024 (4 months ago) • Business Wire

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Tuesday 27 February 2024 (4 months ago) • Business Wire

More Kezar Life Sciences Inc News Articles

JP Morgan Chase

Australia And New Zealan...

Woodside Petroleum

Commonwealth Bank Of Aus...

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions